Abstract:INTRODUCTION AND OBJECTIVES: Oncogenic activation of ERG resulting from prevalent gene fusions (predominantly as TMPRSS2-ERG) is a key driver event in prostate cancer (CaP) pathogenesis.We and others have recently reported that major cancer driver genes, including ERG, show significant racial/ethnic differences in CaP with lower frequencies in African Americans (AA), Africans and Asians.However, there is limited data on germline association with ERG fusion status.The goal of the present study is to agnostically identify the inherited risk variants of CaP incidence and progression by ERG-based stratification of CaP.METHODS: Blood derived genomic DNA samples were prepared from 270 AA men and 130 CA men treated by radical prostatectomy.ERG status was determined by IHC for ERG protein expression.SNP genotyping was performed on the Illumina Golden Gate platform using Infinium Oncoarray SNP chip.Data analysis approaches included association analyses based on EMMAX and imputation analysis by IMPUTE2.SNP genotyping was performed using droplet digital polymerase chain reaction (ddPCR) approach.RESULTS: SNP genotyping analysis was performed in 321 patients with 478,299 SNPs.The SNPs most significantly (p<10-5) associated with ERG fusion status of index tumor included rs6698333 (KLF17) and two SNPs, rs1889877 and rs3798999 (ADGRB3).Four SNPs-rs10215144 (AGBL3); rs3818136, rs9380660 (TBC1D22B region) and rs1792695 in ncRNA (LOC100505474) were found to be significantly (p<10-5) associated with ERG positive status under any tumor foci positive for fusion.Fine-mapping of the genetic associations found rs34349373 and rs2055272 in TBC1D22B to be significantly associated (<10-7) with ERG fusion status by any tumor foci positive for ERG.Imputed SNP rs2055272 was further experimentally validated by ddPCR approach.Concordance between TaqMan and imputed genotypes was 98.04% (100/102).rs34349373 was found to be significantly associated with CA.KaplaneMeier analysis indicated no association (p ¼ 0.9206) between the SNP and biochemical recurrence (BCR).Additional clinicopathological and functional eQTL analysis for the top hits are being performed to understand the biological function of the SNP with ERG fusion status.CONCLUSIONS: This study identified SNPs in TBC1D22B associated with ERG status of CaP, a major driver oncogene in CaP.Although the biological significance of these SNPs still needs to be determined as it relates to ERG status, independent validation may enhance markers in stratifying patients early (even before CaP is detected) for targeted prevention and/or treatment options.

ERG Rearrangement is Associated with Prostate Cancer-Related Death in Chinese Prostate Cancer Patients.

Chinese and Western Prostate Cancers Show Alternate Pathogenetic Pathways in Association with ERG Status.

[Prognostic Significance of ERG Gene Rearrangement and Protein Expression in Prostate Cancer].

Characteristic analysis of ETS gene rearrangement in prostate cancer

The Expression Profile and Heterogeneity Analysis of ERG in 633 Consecutive Prostate Cancers from a Single Center

The Different Genetic Alterations Between Western and Chinese Prostate Cancers and the Underlying Mechanisms.

ERG Rearrangement As a Novel Marker for Predicting the Extra-Prostatic Extension of Clinically Localised Prostate Cancer.

Frequent Discordance Between ERG Gene Rearrangement and ERG Protein Expression in a Rapid Autopsy Cohort of Patients with Lethal, Metastatic, Castration-Resistant Prostate Cancer.

ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasis.

Prognostic value of E‑26 transformation‑specific‑related gene in prostate cancer based on immunohistochemistry analysis

ERG Gene Rearrangement Status in Prostate Cancer Detected by Immunohistochemistry

ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease.

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

ERG Protein Expression is of Limited Prognostic Value in Men with Localized Prostate Cancer.

MP70-11 REVERSE OF DOCETAXEL RESISTANCE IN PROSTATE CANCER VIA NOTCH SIGNALING INHIBITION

TMPRSS2-ERG fusion gene in a cohort of chinese prostatectomy patients and its relevence with clinicopathologic characters and prognosis for endocrine therapy

Overexpression of Truncated ERG from TMPRSS2-ERG Fusion and Prostate Cancer Development

MP90-16 THE ROLE OF PARP2 IN PROSTATE CANCER GROWTH AND PROGRESSION

Comparison of Erg Oncoprotein Expression among Matched Cohorts of African American and Caucasian American Patients with Prostate Cancer

MP70-10 ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS WITH ERG FUSION STATUS IN PROSTATE CANCER

Prevalence and Genetic Features of TMPRSS2-ERG Fusion in Chinese Patients with Prostate Cancer.